FutureSearch Trials of Neurology, LP

Austin, Texas 78731

0 studies enrolling now · 14 studies all time

What they study most

Acute Migraine, B Vitamin Deficiency, Chronic Low Back Pain, Diabetic Peripheral Neuropathy, Excessive Daytime Sleepiness, Idiopathic Hypersomnia, Insomnia Disorder, Insomnia Disorders, Migraine, With or Without Aura, Narcolepsy, Obstructive Sleep Apnea, Osteoarthritis, Hip

Studies at this site

• A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia — Completed
• A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause — Completed
• A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder — Completed
• A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia — Completed
• Open Label Safety Study in Acute Treatment of Migraine — Completed
• Safety and Efficacy Study in Adult Subjects With Acute Migraines — Completed
• Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep — Completed
• Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep — Completed
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" — Completed
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" — Completed
• "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" — Completed
• DFN-02 Open Label Safety Study in Patients With Acute Migraine — Completed
• Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP) — Completed
• The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN) — Status unconfirmed